Table 2.
Effects of TAU-CL, AZA, and their combination on percentage of sperm motility, epididymal count (106/ml) and sperm vitality (Live: Death ratio)
| Groups | Group I (Control) |
Group II (TAU-CL) |
Group III (AZA) |
Group IV (TAU-CL/AZA) |
|---|---|---|---|---|
| Parameters | ||||
| Sperm motility (%) | 90.45 ± 5.01 | 88.5 ± 4.51 | 51.59a ± 1.59 | 86.13b ± 4.32 |
| Caudal epididymal sperm count (106/ml) | 95.01 ± 2.15 | 92.3 ± 2.21 | 30.75a ± 2.66 | 89.99b ± 3.65 |
| Sperm vitality (live: dead ratio) | 14.15 ± 1.02 | 13.8 ± 1.31 | 5.95a ± 0.65 | 13.01b ± 1.25 |
Assessment of percentage of sperm motility, epididymal count (106/ml) and sperm vitality (Live: Death ratio) in the experimental groups; Control, TAU-CL, AZA, TAU-CL/AZA. Data are presented as the mean ± SEM, and data were analyzed using one-way ANOVA followed by the Bonferroni post hoc multiple comparison test (n = 10). Differences between groups were considered statistically significant at P ≤ 0.05. (a) Significant versus the control group. (b) Significant versus the AZA group